SCHEMBL2925439

SCHEMBL2925439

O=S(=O)(Cl)c1ccc(C2CC2)cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV4 Q9HBA0 2/20 0.47
SLC6A2 P23975 8/20 0.37
SLC6A4 P31645 8/20 0.37
SLC6A3 Q01959 8/20 0.37
KCNH2 Q12809 5/20 0.37
CYP2D6 P10635 4/20 0.37
HSD11B1 P28845 1/20 0.36
SMURF2 Q9HAU4 1/20 0.36
SMURF1 Q9HCE7 1/20 0.36
WDR5 P61964 1/20 0.35
MRGPRX4 Q96LA9 1/20 0.35
USP5 P45974 1/20 0.34
LMNA P02545 1/20 0.33
HTT P42858 1/20 0.33
GSTO1 P78417 1/20 0.33
CYP2C8 P10632 1/20 0.32
PTGDR Q13258 1/20 0.32
PTGDR2 Q9Y5Y4 1/20 0.32
PRKAB2 O43741 1/20 0.32
PRKAG1 P54619 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3407211 0.84 CA1 (0.43) SLC6A2SLC6A4SLC6A3WDR5LMNA
SCHEMBL2921647 0.80 PIK3C3 (0.37) TRPV4HSD11B1WDR5USP5
SCHEMBL2954709 0.80 WDR5 (0.40) TRPV4HSD11B1WDR5LMNAHTT
SCHEMBL6951702 0.77 CYP2C8 (0.41) SLC6A2SLC6A4SLC6A3KCNH2CYP2D6
SCHEMBL25318742 0.76 TRPV4 (0.58) TRPV4
SCHEMBL19682382 0.76 TRPV4 (0.39) TRPV4WDR5
SCHEMBL2746854 0.74 ACMSD (0.38) SLC6A2SLC6A4SLC6A3KCNH2CYP2D6
SCHEMBL9870878 0.73 SLC6A2 (0.58) SLC6A2SLC6A4SLC6A3KCNH2CYP2D6
SCHEMBL29519358 0.71 TRPV4 (0.57) TRPV4HSD11B1LMNA
SCHEMBL444929 0.71 TRPV4 (0.57) TRPV4HSD11B1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10889555-B2 Sulfonamide compound or salt thereof TAIHO PHARMACEUTICAL CO., LTD. (JP) 2021-01-12 US disclosed
US-20200405697-A1 Antitumor Agent TAIHO PHARMACEUTICAL CO., LTD. (JP) 2020-12-31 US disclosed
US-20200399235-A1 Sulfonamide Compound or Salt Thereof TAIHO PHARMACEUTICAL CO., LTD. (JP) 2020-12-24 US disclosed
EP-3718545-A1 ANTITUMOR AGENT Taiho Pharmaceutical Co., Ltd. (JP) 2020-10-07 EP disclosed
US-20200157066-A1 Sulfonamide Compound or Salt Thereof TAIHO PHARMACEUTICAL CO., LTD. (JP) 2020-05-21 US disclosed
WO-2017209155-A1 SULFONAMIDE COMPOUND OR SALT THEREOF 大鵬薬品工業株式会社 2017-12-07 WO disclosed
EP-2231595-B1 PHENYL ACETIC ACID DERIVATIVES AS INFLAMMATION MODULATORS AMGEN INC (US) 2014-04-23 EP disclosed
US-8183293-B2 Phenyl acetic acid derivatives AMGEN INC. (US) 2012-05-22 US disclosed
US-8183293-B2 Phenyl acetic acid derivatives AMGEN INC. (US) 2012-05-22 US disclosed
CN-101878197-A Method for producing 3-mercaptoaniline compound IHARA CHEMICAL IND CO 2010-11-03 CN disclosed
EP-2231595-A1 PHENYL ACETIC ACID DERIVATIVES AS INFLAMMATION MODULATORS Amgen, Inc (US) 2010-09-29 EP disclosed
EP-2226312-A1 METHOD FOR PRODUCING 3-MERCAPTOANILINE COMPOUND IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2010-09-08 EP disclosed
US-20090275659-A1 Phenyl acetic acid derivatives as inflammation modulators AMGEN INC. (US) 2009-11-05 US disclosed
US-20090275659-A1 Phenyl acetic acid derivatives as inflammation modulators AMGEN INC. (US) 2009-11-05 US disclosed
WO-2009085177-A1 PHENYL ACETIC ACID DERIVATIVES AS INFLAMMATION MODULATORS AMGEN INC. (US) 2009-07-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200399235-A1 Sulfonamide Compound or Salt Thereof RNASEH1, SNRPA1, RRM2 TRPV4 1831/4885SLC6A2 2561/4885SLC6A4 1546/4885
US-20200157066-A1 Sulfonamide Compound or Salt Thereof RNASEH1, SNRPA1, RRM2 TRPV4 1831/4885SLC6A2 2561/4885SLC6A4 1546/4885
US-10889555-B2 Sulfonamide compound or salt thereof RNASEH1, SNRPA1, RRM2 TRPV4 1831/4885SLC6A2 2561/4885SLC6A4 1546/4885
US-20090275659-A1 Phenyl acetic acid derivatives as inflammation modulators NFKBIA, HCAR2, NFATC1 TRPV4 775/4885SLC6A2 4340/4885SLC6A4 4201/4885
US-20200405697-A1 Antitumor Agent HNRNPR, RRM2, RRM2B TRPV4 3337/4885SLC6A2 2526/4885SLC6A4 1836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.